OMB Home White House Website

Agency:    Department of Defense--Military
Bureau:    Research, Development, Test, and Evaluation
Account:    Research, development, test, and evaluation, Army (21-2040)
Certifying Official:    Deputy Comptroller Program/Budget
Contact Information:    http://WWW.DOD.GOV   703-697-5131
Chemical-Biological Casualty Treatment (Note: transferred from RDTE,A line 154)

1 recipient will receive $2,396,000. This is a continuing earmark.
Year Enacted: 2005
Description: This proposal objective will focus on the need to effect changes in our medication management process that could yield notable improvements in patient safety, clinical effectiveness, and efficiency. Holy Name Hospital has a medication management redesign that describes a strategy for incorporation and integrating technology that attempts to close the loop for error reduction, ADE (adverse drug events) detection, and integrated data collection in a manner that is unique according to feedback from vendors and literature.
Beneficiary/Recipient Amount ($K) Program Type Address
Holy Name Hospital $2,396 For-Profit
Teaneck, NJ
Source: Appropriations Report Language - Conference
Reference: 108-622
Location: Line 117, Page 267
Citation Excerpt: Chemical-Biological Casualty Treatment (Note: transferred from RDTE,A line 154)

Last Modified: 16-Apr-2007

Federal Register    |   Jobs at OMB   |   FOIA   |  OMB Locator   |   |   Accessibility   |   Privacy Policy   |   Site Search   |   Help